8-K current report · filed Nov 3, 2026

Indivior Pharmaceuticals, Inc. (INDV) 8-K Current Report: November 3, 2026

Item 8.01INDV overview

Short answer

Indivior Pharmaceuticals, Inc. (INDV) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 8.01 (Other Events). Special Dividend triggered an adjustment to the 0.625% convertible notes due 2031.

Indivior Pharmaceuticals, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • Special Dividend triggered an adjustment to the 0.625% convertible notes due 2031
  • Conversion rate increased from 24.0033 to 30.9355 shares per $1,000 principal
  • Effective conversion price approximately $32.33 per share, increasing potential dilution
  • No bondholders converted, so no immediate share issuance or dilution occurred

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Indivior Pharmaceuticals, Inc. 8-K filings

Get the next INDV 8-K as it lands

Follow INDV for push alerts, or ask the research agent what this filing means.